Latest Roche Stories
MANNHEIM, Germany, Feb.
Focus on cancer vaccines, auto-immune disease diagnostics and treatment DALLAS, Dec.
PRINCETON, N.J., Nov. 23, 2010 /PRNewswire-FirstCall/ -- Pharmasset, Inc.
SAN DIEGO, Nov. 5, 2010 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc.
SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc.
NUTLEY, N.J. and BASEL, Switzerland Oct. 4 /PRNewswire/ -- Roche announced today that Jacques Banchereau, Ph.D., has joined Roche as Senior Vice President and Head of the Inflammation and Virology Discovery and Translational Areas (DTAs).
NUTLEY, N.J., Sept.
IPSWICH, Mass., Aug. 4 /PRNewswire/ -- New England Biolabs is pleased to announce that Canada's Michael Smith Genome Sciences Center has selected New England Biolabs as one of its key suppliers for next-generation sequencing library construction reagents.
NUTLEY, N.J., July 26 /PRNewswire/ -- Roche announced today that Karen Lackey has been named Vice President and Head of Medicinal Chemistry, effective immediately.
Federal health scientists said Friday that follow-up studies of a Roche breast cancer drug showed it failed to slow tumor growth or extend patient lives.
- Large; stout; burly.